TB-500 vs Retatrutide
Compare the research profiles of TB-500 and Retatrutide. Read the individual guides for evidence and limitations.
How to interpret this comparison
This page summarizes database profiles and has not yet received a study-by-study editorial review. These compounds are filed under different research categories, so a direct treatment comparison may not answer a meaningful clinical question. Use the linked guides and primary sources to evaluate a specific claim.
How to read peptide studiesTB-500
Thymosin Beta-4 Fragment
healing
Preclinical (Animal Studies)
not-approved
Retatrutide
Retatrutide (LY3437943)
weight-loss
Phase 3 Clinical Trials
clinical-trials
Detailed Comparison
| Aspect | TB-500 | Retatrutide |
|---|---|---|
| Overview | A synthetic version of a naturally occurring peptide present in virtually all human and animal cells. Studied for cellular regeneration and wound healing properties.... | A triple hormone receptor agonist (GLP-1/GIP/Glucagon) in clinical trials by Eli Lilly. Shows remarkable weight loss results up to 29% body weight. Often misleadingly called "GLP-3" on gray market.... |
| Research topics (not established benefits) |
|
|
| Side Effects |
|
|
| Mechanism | Promotes cell migration, blood vessel formation, and regulates actin, a protein that forms cell structure. May reduce inflammation and promote tissue ... | Activates three receptors simultaneously: GLP-1, GIP, and glucagon. The glucagon component may provide additional metabolic benefits and fat burning.... |
Frequently Asked Questions
Does a comparison establish which treatment is better?
Only appropriately designed evidence for the same clinical question can support that conclusion. Database categories and mechanisms alone cannot rank treatments.
Does this page establish that these compounds can be combined?
No. This page does not assess interactions or the benefit and safety of combined use. Individual studies cannot establish the effects of a combination.